Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type of the Canadian alteplase for stroke effectiveness study registry.
Richard
R
Libman
Thomas
T
Kwiatkowski
D002170:Canada; D002543:Cerebral Hemorrhage / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011379:Prognosis; D012042:Registries; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator